Jilin Aodong's 2026 Half-Year Report: Net Profit Attributable to Parent Soars Nearly 60% Year-on-Year

Earnings
โดย 证券时报·CN·Read original
Summary · why it matters

Jilin Aodong has released its 2026 semi-annual report, showing net profit attributable to the parent company up nearly 60% year-on-year, with significant results from its dual-driven strategy of industry and finance. As of the end of June, the company's total assets reached 36.049 billion yuan, net assets stood at 31.989 billion yuan, and the asset-liability ratio was only 10.66%. In the first half of the year, operating revenue was 1.031 billion yuan, down 8.47% year-on-year, but net profit attributable to the parent reached 2.05 billion yuan, a sharp increase of 59.96%, mainly due to a substantial rise in investment income. As the largest shareholder of GF Securities, investment income for the period was 2.173 billion yuan, up 80.17% year-on-year. On the pharmaceutical main business side, revenue from the traditional Chinese medicine segment was 658 million yuan, accounting for 63.78% of total revenue, while the chemical pharmaceuticals, chain pharmacy, and broader health segments also developed steadily. The company continues to deepen the integration of industry and finance, having established five industrial funds with GF Xinde, focusing on investments in areas such as biopharmaceuticals.

Impact on stocks 2

Others▲ · 2 stocks
GF Securities Co Ltd
000776
▲ PositiveCapitalrelevance

As largest shareholder, Jilin Aodong's investment income from GF Securities rose 80.17%, reflecting GF's strong performance.

Off-coverage companies 1

东莞广发信德一期科技创业投资合伙企业Private± Mixed
relevance

© 2026 MarketDXNews